Hype to HIGH IMPACT: AI ImplEMEntation From Discovery to Delivery

23 - 25 September 2025 | Amsterdam

View 2025 Agenda

PARTNER WITH US

BOOK YOUR PLACE

Slava Akmaev

Executive Vice President, Chief Operating Officer & Chief AI Officer BPGbio

Agenda Day 1

2:30 PM CLINICAL TRIALS - USING CAUSAL AI TO DRIVE CLINICAL DEVELOPMENT IN ONCOLOGY FOR A NEW MOLECULAR ENTITY

Slava Akmaev, CAIO and COO at BPGbio, Inc will talk about applications of the NAi Interrogative Biology(r) platform to guide clinical development of BPM31510 in oncology.

Key takeaways:

AI and multi-omic human data can be effective at elucidating compound MoA.
Finding the right oncology indication for your asset is paramount for clinical success. Tumorigenesis is not always explained by driving mutations. Causal AI gives an unbiased and comprehensive perspective on indication selection.
Precision medicine in oncology needs to reach beyond somatic mutations and study cancer in the context of the human tissue and its microenvironment. AI supports biomarker discovery and population selection.

Check out the incredible speaker line-up to see who will be joining Slava.

Download The Latest Agenda

In Partnership With:

QUESTIONS?

Address: IQPC Ltd, 129 Wilton Road,
London SW1V 1JZ
Telephone: +44 (0) 1135 210 042
Fax: 44 (0) 207 368 9301
Email: enquire@iqpc.co.uk